David Taber to Hypertension
This is a "connection" page, showing publications David Taber has written about Hypertension.
Connection Strength
0.936
-
Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
Score: 0.237
-
Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
Score: 0.224
-
Ambulatory Care Coordination Issues With Dual Use Veteran Organ Transplant Recipients. Prog Transplant. 2017 06; 27(2):187-191.
Score: 0.071
-
Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017 Apr; 213(4):666-672.
Score: 0.070
-
Sustainability of improvements in medication adherence through a mobile health intervention. Prog Transplant. 2015 Sep; 25(3):217-23.
Score: 0.064
-
Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28.
Score: 0.059
-
Hypertension after kidney transplantation: a pathophysiologic approach. Curr Hypertens Rep. 2013 Oct; 15(5):458-69.
Score: 0.056
-
The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50.
Score: 0.053
-
Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies. Ann Pharmacother. 2010 Jul-Aug; 44(7-8):1259-70.
Score: 0.045
-
Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Ann Pharmacother. 2008 Jan; 42(1):116-20.
Score: 0.038
-
Ethnic and geographic variations in multimorbidty: Evidence from three large cohorts. Soc Sci Med. 2018 08; 211:198-206.
Score: 0.019